America, since the conclusion of World War II, has dominated the R&D pipeline. Past research from our team at the Center for ...
Social media platforms have created new complications for people with bipolar disorder when evidence of their manic episodes ...
2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of ...
At the time, Humana was in the midst of a nearly $2 billion expansion of the clinics across 15 states, and CEO Bruce ...
Worsham and Jena are physicians and researchers at Harvard Medical School and the authors of “Random Acts of Medicine: The ...
It is not obvious to me that this is a threat," one expert said about President Trump's calling fentanyl a weapon.
As Robert F. Kennedy Jr. signals a fat-friendlier approach to dietary guidelines, a new review offers fodder for opposing ...
In a memo obtained by STAT, the NIH gives specific steps on how grant reviewers can check for alignment with administration ...
The Medicare prescription drug plan market appears to be under a lot of stress. And taxpayers are forking over record amounts ...
Sanofi flagged a second delay to an FDA decision for its experimental multiple sclerosis drug and reported disappointing ...
Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...
A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback